[1] DHANDAYUTHAPANI S,MARIMUTHU P,HORMANN V,et al. Induction of apoptosis in HeLa cells via caspase activation by resveratrol and genistein[J]. J Med Food,2013,16(2):139.
[2] GIMENEZ-BONAFE P,TORTOSA A,PEREZ-TOMAS R. Overcoming drug resistance by enhancing apoptosis of tumor cells[J]. Curr Cancer Drug Targets,2009,9(3):320.
[3] CHENG B,YANG X,HAN Z,et al. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA[J]. Auris Nasus Larynx,2008,35(1):95.
[4] LI DW, GAO S, SHEN B, et al. Effect of apoptotic and proliferative indices, P-glycoprotein and survivin expression on prognosis in laryngeal squamous cell carcinoma[J]. Med Oncol, 2011,28(Suppl 1):333.
[5] TSUJIMOTO Y, COSSMAN J, JAFFE E, et al. Involvement of thebcl-2 gene in human follicular lymphoma[J]. Science,1985, 228(4706):1440.
[6] 董雅洁,高维娟. bcl-2、bax、caspase-3在细胞凋亡中的作用及其关系[J].中国老年学杂志,2012,21(32):4828.
[7] LUANPITPONG S,CHANVORACHOTE P,STEHLIK C,et al. Regulation of apoptosis by Bcl-2 cysteine oxidation in human lung epithelial cells[J]. Mol Biol Cell,2013,24(6):858.
[8] 吴曙辉,江孝清,龚齐. PUMA、Bcl-2在喉鳞状细胞癌组织中的表达及临床意义[J].山东医药,2010,50(9):89.
[9] GEORGIOU A,GOMATOS IP,PARARAS NB,et al. Cell kinetics and apoptosis in laryngeal carcinoma patients[J]. Ann Otol Rhinol Laryngol,2003,112(3):206.
[10] 游龙贵,孙炜,孙彦.喉癌手术切缘Bcl-2、Bax及BaK蛋白的表达[J].青岛大学医学院学报,2005,41(1):40.
[11] 杜锦朵,田从哲,吴艳钦.喉癌手术切缘中p53、Bcl-2、Survivin的表达与预后关系[J].现代预防医学,2008,35(22):4454.
[12] CROOK NE, CLEM RJ, MILLER LK. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif[J]. J Virol,1993, 67(4):2168.
[13] DYNEK JN, VUCIC D. Antagonists of IAP proteins as cancer therapeutics[J]. Cancer Lett,2013,332(2):206.
[14] AMBROSINI G,ADIDA C,ALTIERI DC. A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma[J]. Nat Med, 1997,3(8):917.
[15] MITA AC,MITA MM,NAWROCKI ST. Survivin:key regulator of mitosis and apoptosis and novel target for cancer therapeutics[J]. Clin Cancer Res,2008,14(16):5000.
[16] ALTIERI DC. Survivin and IAP proteins in cell-death mechanisms[J]. Biochem J,2010,430(2):199.
[17] SUZUKI A, ITO T, KAWANO H, et al. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death[J]. Oncogene,2000, 19(10):1346.
[18] MARIONI G,D'ALESSANDRO E,BERTOLIN A,et al. Survivin multifaceted activity in head and neck carcinoma:current evidence and future therapeutic challenges[J]. Acta Otolaryngol,2010,130(1):4.
[19] GARCIA-FERNANDEZ E,DE DIEGO JI,COLLANTES-BELLIDO E,et al. Aurora B kinase expression in laryngeal squamous cell carcinoma and its prognostic implications[J]. Histopathology, 2011,58(3):368.
[20] MARIONI G, AGOSTINI M, BEDIN C, et al. Survivin and laryngeal carcinoma prognosis:nuclear localization and expression of splice variants[J]. Histopathology,2012,61(2):247.
[21] DONG Y,SUI L,WATANABE Y,et al. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications[J]. Anticancer Res,2002,22(4):2377.
[22] 郑世辉. Survivin在喉鳞癌组织中的表达及临床病理特征[J].中国现代医生,2012,50(14):46.
[23] LIN JH,DENG G,HUANG Q,et al. KIAP,a novel member of the inhibitor of apoptosis protein family[J]. Biochem Biophys Res Commun,2000,279(3):820.
[24] VUCIC D,FRANKLIN MC,WALLWEBER HJ,et al. ML-IAP,a novel inhibitor of apoptosis that is preferentially expressed in human melanomas[J]. Curr Biol,2000,10(21):1359.
[25] CHEN YS,LI HR,LIN M,et al. Livin abrogates apoptosis of SPC-A1 cell by regulating JNKI signaling pathway[J]. Mol Biol Rep, 2010,37(5):2241.
[26] VUCIC D,FRANKLIN MC,WALLWEBER HJ,et al. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor:implications for Smac-dependent anti-apoptotic activity of ML-IAP[J]. Biochem J,2005,385(Pt 1):11.
[27] 张翼翔,马长宏.凋亡抑制蛋白Livin的最新研究与应用[J].实用肿瘤学杂志,2009,3(23):275.
[28] SANNA MG,DA SILVA CORREIA J,DUCREY O,et al. IAP suppression of apoptosis involves distinct mechanisms:the TAK1/JNK1 signaling cascade and caspase inhibition[J]. Mol Cell Biol, 2002,22(6):1754.
[29] 万保罗,董俊华,马崧,等. Livin基因在喉癌组织中mRNA表达及其意义[J].医药论坛杂志,2011,32(23):46.
[30] 徐勤,高珊. Livin和Caspase-3在喉鳞癌组织中表达的意义及相关性分析[J].天津医药,2012,40(12):1206.
[31] 李彩霞,冯艳. p53基因与肝癌[J].医学影像学杂志,2006,16(10):1105.
[32] CRIGHTON D,WILKINSON S,O'PREY J,et al. DRAM,a p53-induced modulator of autophagy,is critical for apoptosis[J]. Cell, 2006,126(1):121.
[33] CAIN C, MILLER S, AHN J, et al. The N terminus of p53 regulates its dissociation from DNA[J]. J Biol Chem,2000,275(51):39944.
[34] LEVINE AJ,FINLAY CA,HINDS PW. p53 is a tumor suppressor gene[J]. Cell,2004,116(2 Suppl):S67.
[35] MORTON JP,KANTIDAKIS T,WHITE RJ. RNA polymerase Ⅲtranscription is repressed in response to the tumour suppressor ARF[J]. Nucleic Acids Res,2007,35(9):3046.
[36] 罗克强,王直中,王娜亚. p53在喉鳞状细胞癌及癌旁组织中的表达与生物学行为的关系及意义[J].临床耳鼻咽喉科杂志,2005,19(9):405.
[37] WOLF BB,SCHULER M,ECHEVERRI F,et al. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation[J]. J Biol Chem,1999,274(43):30651.
[38] 潘科,刘丽娜,卢书明,等.凋亡相关蛋白Caspase-9与Bax在胃癌中的表达以及与凋亡的关系[J].贵阳医学院学报, 2009,34(4):402.
[39] WU XX,KAKEHI Y,JIN XH,et al. Induction of apoptosis in human renal cell carcinoma cells by vitamin E succinate in caspase-independent manner[J]. Urology,2009,73(1):193.
[40] 李珂,郝艳,王建亭,等. Omi/HtrA2和caspase-7在喉癌组织中的表达及相关性[J].山西医科大学学报,2011,42(7):583.
[41] 孟凡生,高珊,徐勤,等. Caspase-3蛋白在喉鳞癌组织中表达及与喉癌细胞凋亡的对比研究[J].临床和实验医学杂志, 2013,12(4):258.
[42] LEONARDOS L,BUTLER LM,HEWETT PJ,et al. The activity of caspase-3-like proteases is elevated during the development of colorectal carcinoma[J]. Cancer Lett,1999,143(1):29.
[43] 杜锦朵,田从哲,吴艳钦,等.喉癌手术切缘中p53、Bcl-2、Survivin的表达与预后关系[J].现代预防医学,2008,35(22):4454.